TOP20 retail products of Chinese patent medicinal plasters released, 4 products rose by more than 30%

With the increasing aging of our country's population, the market size of proprietary Chinese medicine plasters will further expand, and retail pharmacies are one of its main sales channels
.
The latest data from Meinenet shows that in recent years, the sales of proprietary Chinese medicine plasters in physical pharmacies in cities in China have maintained steady growth.
Last year, it was affected by the epidemic and declined slightly.
It is expected to return to the right track in 2021, with a year-on-year increase of 5.
10%
.
The total market share of TOP20 products exceeds 80%.
Among them, 11 are exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Wuxi Pharmaceutical, Yabao Pharmaceutical, Henan Lingrui Pharmaceutical and other enterprises, and Xiaotong Plaster is stable "Yi Ge" throne, sales reached a new high; in terms of growth rate, 4 products including waist and kidney ointment and red medicine plaster all rose by more than 30%
.
Among the TOP20 brands, 11 have sales of more than 100 million yuan; in terms of the number of brands, Lingrui Pharmaceutical has the most, with 6 brands
.
It is worth mentioning that 11 pharmaceutical companies including Tibet Qizheng Tibetan Medicine and Henan Lingrui Pharmaceutical were selected in the list of national technological innovation demonstration enterprises for 2021 announced on the official website of the Ministry of Industry and Information Technology
.
TOP20 Chinese patent medicinal plasters are released! The sales of 11 brands exceeded 100 million yuan, and the two leading two were selected as national technological innovation demonstration enterprises.
Sales of proprietary Chinese medicine plasters in Chinese urban physical pharmacies in recent years (unit: 100 million yuan) Source: Mi Nei.
com.
Chinese urban physical pharmacy terminal competition pattern.
The latest data of Mi Nei.
In recent years, the market for proprietary Chinese medicine plasters in physical pharmacies in cities in China has maintained steady growth, and sales due to the epidemic will decline slightly in 2020.
It is expected to return to the right track in 2021, with a year-on-year increase of 5.
10%
.
2021E TOP20 proprietary Chinese medicine plaster products in physical pharmacies in cities in China (unit: 100 million yuan) Source: Mi Nei.
com.
Competitive landscape of physical pharmacies in Chinese cities in 2021E.
Note: Less than 100 million yuan is used to indicate that the TOP20 market is highly concentrated, and the total market share exceeds 80%, there are as many as 15 products with sales of more than 100 million yuan, an increase of 1 compared with 2020
.
Xiaotong Plaster is firmly on the throne of "Big Brother", and sales are expected to reach a new high in 2021; Musk Zhuanggu Ointment and Yunnan Baiyao Ointment will follow closely behind
.
From the perspective of treatment categories, orthopedic analgesics used the most, with 10; followed by bruises, with 4
.
It is worth noting that among the TOP20 products, there are as many as 11 exclusive products, involving Tibet Qizheng Tibetan Medicine, Yunnan Baiyao Wuxi Pharmaceutical, Yabao Pharmaceutical, Henan Lingrui Pharmaceutical and other companies
.
2021E TOP20 brand of proprietary Chinese medicine plasters in physical pharmacies in cities in China (unit: 100 million yuan) Source: Mi Nei.
com.
Competitive pattern of physical pharmacies in Chinese cities in pharmacies.
Note: For less than 100 million yuan, use * to indicate that 11 of the TOP20 brands have sales of more than 1 100 million yuan
.
In terms of the number of brands, Henan Lingrui Pharmaceutical has the most, with six
.
It is worth mentioning that a few days ago, the official website of the Ministry of Industry and Information Technology announced the list of national technological innovation demonstration enterprises in 2021, and 11 pharmaceutical enterprises including Tibet Qizheng Tibetan Medicine and Henan Lingrui Pharmaceutical were selected
.
Xiaotong Plaster has reached a new high.
Lingrui's 6 major brands are eye-catching.
Sales of terminal Xiaotong Plasters in Chinese urban physical pharmacies in recent years (unit: 100 million yuan) Source: Mynet.
com.
The exclusive product of Tibet Qizheng Tibetan Medicine, in recent years, the terminal sales of physical pharmacies in Chinese cities have exceeded 600 million yuan, and it is expected to reach a new high in 2021
.
Recently, a brokerage agency conducted research on Qizheng Tibetan Medicine and asked questions about the company's convertible bond fundraising project progress, future sales revenue, and product competitive advantages.
Qizheng Tibetan Medicine stated that the company's strategy is one axis, two wings and three supports
.
"One axis" is to strengthen analgesia, with Xiaotong Plaster, Qingpeng Ointment, Baimai Ointment, and Ruyi Zhenbao Tablets as the core to strengthen the area of ​​analgesia
.
"Two Wings" on the one hand develop the second and third echelon, expand the department of gynecology, expand the pediatrics, explore the field of medical skin care products, develop specialties of Tibetan medicine, promote the characteristics of Tibetan medicine bath therapy and medicine; on the other hand, start the Internet health marketing of Qizheng Tibetan medicine Platform construction
.
The "three supports" refer to green and intelligent manufacturing, innovating traditional external governance, and activating organizations
.
In addition, through acquisitions, the company has introduced and stocked more than 60 traditional Chinese and Tibetan medicine products covering women and children, cardiovascular and cerebrovascular, digestion, respiratory and other fields, further enriching the product line, broadening the treatment field, and laying a solid foundation for the company's future development
.
The source of the market share of Lingrui's 6 major products in physical pharmacies in Chinese cities in recent years: Meinnet.
com Among the TOP20 brands in the terminal competition pattern of Chinese urban physical pharmacies, Lingrui Pharma has Tongluo Qutong Gao, Zhuanggu Musk Pain Relief Cream, Musk Zhuanggu Ointment, etc.
6 products are on the list, of which Tongluo Qutong Ointment is an exclusive product
.
Meinenet data shows that in recent years, the sales of Tongluo Qutong ointment in physical pharmacies in cities in China have grown rapidly.
It will exceed 200 million yuan in 2020 and is expected to increase again by nearly 4% in 2021
.
In addition, Lingrui Pharmaceutical's Musk Zhuanggu Paste and Shufu Paste both grew faster than 30%
.
According to data, Lingrui Pharmaceutical's main products focus on the three major areas of orthopedics, cardio-cerebrovascular, and anesthesia.
In the first half of this year, orthopedic topical preparations have grown rapidly, and cardio-cerebrovascular and anesthetics have maintained steady growth
.
Some brokerage analysts indicated that driven by aging and consumption upgrades, there is still room for brand product market share to increase
.
Lingrui Pharmaceutical has a rich product line of plasters.
In addition to Tongluo Qutong plaster, there are also a series of plaster products such as Zhuanggushexiang Pain Relief plaster to meet the needs of different levels of markets and patients
.
The growth rate of 4 major products exceeds 30%! Yaoshen ointment becomes the "king of growth rate" with a growth rate of over 30%.
Source of information about proprietary Chinese medicine plaster products: One-key retrieval from Meinenet.
From the perspective of growth rate, among the TOP20 products, Yaoshen ointment, red medicine plaster, and abdomen The 4 products, stick plaster and Tiebanghammer pain relief plaster, all exceed 30%
.
Among them, 3 are exclusive products, and waist and kidney ointment has the fastest growth rate
.
In recent years, the sales of waist and kidney ointment at physical pharmacies in cities in China (unit: 100 million yuan) Source: Mi Nei.
com.
The terminal competition pattern of physical pharmacies in cities in China.
Sore waist and knees, muscle aches, etc.

.
According to data from Mi Nei.
com, it is expected that the sales of terminal lumbar kidney ointment in public medical institutions in China will exceed 100 million yuan in 2021, a year-on-year increase of more than 60%
.
According to the data, Sinopharm Dezhong (Foshan) Pharmaceutical is one of the key enterprises in China's proprietary Chinese medicine sector.
In the first half of this year, it has increased the investment of terminal promotion resources such as chain pharmacies.
The sales of product regulations have increased significantly
.
Source: Meinenet database, company announcement Note: Meinenet China's urban entity pharmacy terminal competition pattern database covers 293 prefectures and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors the entire category.
Edition city entity pharmacy database
.
The above sales are calculated based on the average retail price of the product at the terminal
.